Clinical and research tests for C1852092 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

<< First< Prev

Page 1 of 2

Results: 1 to 20 of 21

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
INS - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany	4	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Invitae Monogenic Diabetes Panel Invitae United States	59	28	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Monogenic Diabetes Panel PreventionGenetics, part of Exact Sciences United States	101	54	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Diabetes mellitus, insulin-dependent, 2, 125852, Autosomal dominant (INS gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey	1	1	C Sequence analysis of the entire coding region
Dyslipidemia and early atherosclerosis panel. 84-gene NGS panel. Genologica Medica Spain	133	84	C Sequence analysis of the entire coding region
MODY type diabetes panel. NGS panel of 13 genes. Genologica Medica Spain	29	13	C Sequence analysis of the entire coding region
Comprehensive panel of monogenic diabetes. 28-gene NGS panel. Genologica Medica Spain	60	28	C Sequence analysis of the entire coding region
Diabetes mellitus: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada	10	10	C Sequence analysis of the entire coding region
Maturity onset diabetes of the young (MODY) panel Al Jalila Children's Genomics Center Al Jalila Childrens Speciality Hospital United Arab Emirates	15	17	C Sequence analysis of the entire coding region
Expanded Polycystic Kidney Disease NGS Panel Fulgent Genetics United States	61	34	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Maturity-Onset Diabetes of the Young (MODY) NGS Panel Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States	16	14	C Sequence analysis of the entire coding region
Permanent Neonatal Diabetes Mellitus , Panel Massive Sequencing (NGS) 16 Genes Reference Laboratory Genetics Spain	12	16	C Sequence analysis of the entire coding region
Maturity Onset Diabetes of the Young (MODY) Asper Biogene Asper Biogene LLC Estonia	27	15	C Sequence analysis of the entire coding region
INS Gene Sequencing and Deletion/Duplication Analysis DDC Clinic Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children United States	4	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
INS Single Gene Fulgent Genetics United States	3	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Clinical Exome Fulgent Genetics United States	5129	4672	D Deletion/duplication analysis C Sequence analysis of the entire coding region
MODY Neonatal Diabetes NGS Panel Fulgent Genetics United States	56	30	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Hyperinsulinism NGS Panel Fulgent Genetics United States	41	21	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Diabetes-Obesity NGS Panel Fulgent Genetics United States	73	56	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Diabetes mellitus, insulin-dependent, 2 MedGene Slovakia	1	1	C Sequence analysis of the entire coding region

<< First< Prev

Page 1 of 2

Results: 1 to 20 of 21

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.